Physician profile
Robert E Sanders
NPI 1932188216
$1,318.53
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $159 · 2021: $510 · 2022: $112.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $213.88 | 2019-2021 | |
| Abbvie INC. | $204.58 | 2021-2022 | |
| Radius Health, INC. | $179.06 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.22 | 2019 | |
| Amarin Pharma, INC. | $128.12 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $91.63 | 2019 | |
| Novo Nordisk INC | $63.73 | 2020-2022 | |
| Biohaven Pharmaceuticals, INC. | $55.27 | 2021 | |
| Merck Sharp & Dohme LLC | $54.17 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $21.00 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $20.45 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.28 | 2021 | |
| Neurocrine Biosciences, INC. | $16.08 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.48 | 2019 | |
| Glaxosmithkline, LLC. | $14.27 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $13.32 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $13.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.65 | 2022 | |
| Allergan, INC. | $12.40 | 2020 | |
| Lilly USA, LLC | $12.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.72 | 2020 | |
| Esperion Therapeutics, INC. | $11.22 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sanders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.